Pregnancy Associated Plasma Peptide A (PAPPA)

A large zinc-binding protein. PAPPA has been used in prenatal genetic screening and studies of atherosclerosis. Women with low blood levels of PAPPA at 8 to 14 weeks of gestation have an increased risk of intrauterine growth restriction, trisomy 21, premature delivery, preeclampsia, and stillbirth.
PAPPA is present in unstable atherosclerotic plaques, and circulating blood levels are elevated in acute coronary syndromes. PAPPA may also be a marker of unstable angina and acute myocardial infarction.


Product:
PAPPA - native
 
Cat No:
P390-5
 
Specification:
>80% Pure
 
Source:
Human Serum
 
Min Pk:
100 µg
 
Presentation:
0.05 phosphate buffer pH 7.5 containing 0.15M NaCl and 0.09% NaN3
 
Storage:
<-15°C
 
add to myPAC Literature PDF MSDS PDF Typical Certificate of Analysis
 
Product:
PAPPA - recombinant
 
Cat No:
P389-7
 
Specification:
>95% pure
 
Source:
Recombinant from E. coli
 
Min Pk:
100 µg
 
Presentation:
PBS / Glycerol
 
Storage:
<-15°C
 
add to myPAC Literature PDF MSDS PDF Typical Certificate of Analysis